A Canadian Phase II Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer
Condition: Metastatic Urothelial Carcinoma Interventions: Drug: Bicalutamide 150 mg; Drug: Placebo Sponsors: CHU de Quebec-Universite Laval; Cancer Research Society Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2023 Category: Research Source Type: clinical trials